Contextualizing President Trump's Executive Orders Targeting Transgender Health and Gender-Affirming Care.
Where this comes from
- Record sourced from PubMed, PMID 41166663.
- Also identified by DOI 10.2105/AJPH.2025.308265 and PMC identifier 12801737.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The antitransgender executive orders and legislation enacted by the Trump administration since January 2025 have focused on enforcing a gender binary and restricting access to gender-affirming care for youths. These actions have had sweeping effects on health policy and access to care in an already strained health care system. Here we contextualize these attacks on transgender health by exploring the historical pathologization and policing of transgender bodies in the United States and Europe while tracing the legacy of medical gatekeeping alongside evolving standards of care. We critique the scientific inaccuracies within the administration's executive orders while outlining the harmful impact of related and recent legislation, including <i>United States v Skrmetti</i>. Restrictions on gender-affirming care and the rights of transgender people to exist not only exacerbate health disparities but also undermine the ethical responsibility of medical practitioners and institutions to provide patient-centered, evidence-based care. We must not capitulate to political efforts that attempt to harm and erase an already marginalized population. (<i>Am J Public Health</i>. 2026;116(2):256-260. https://doi.org/10.2105/AJPH.2025.308265).
Medical subject headings
- Transgender Persons
- Health Policy
- Politics
- Health Services Accessibility